Table 1 Characteristics of studies included in the meta-analysis
Author | Year | Design | Subjects | Sample size | Country | Diary delivery | Follow-up | Tools | Risk of bias |
|---|---|---|---|---|---|---|---|---|---|
Garrouste-Orgeas et al. [13] | 2019 | RCT | Patients and relatives | 657 | France | ICU discharge | 90 days after ICU discharge | HADS, IES-R | High |
Nielsen et al. [12] | 2019 | RCT | Patients and relatives | 116 | Western Denmark | ICU discharge | 90 days after ICU discharge | HADS, PTSS-14, SF-36 | High |
Kredentser et al. [11] | 2018 | RCT | Patients | 58 | Canada | 30 days after ICU discharge | 90 days after ICU discharge | HADS, IES-R | High |
Jones et al. [30] | 2012 | RCT | Relatives | 36 | Sweden and the UK | 30 days after ICU discharge | 90 days after ICU discharge | PTSS-14 | High |
Jones et al. [8] | 2010 | RCT | Patients | 352 | Denmark, Italy, Norway, Portugal, Sweden, and the UK | 30 days after ICU discharge | 90 days after ICU discharge | PDS, PTSS-14 | High |
Knowles et al. [9] | 2009 | RCT | Patients | 36 | UK | 30 days after ICU discharge | 3 weeks | HADS | High |
Fukuda et al. [32] | 2015 | Before-and-after | Patients | 40 | Japan | 1 week after ICU discharge | 10 days after the post-ICU survey and prior to the discharge from the hospital | HADS, ASDS | High |
Garrouste-Orgeas et al. [28] | 2012 | Before-and-after | Patients and relatives | 143 | France | ICU discharge | 3 months (HADS/PDEQ), 12 months (IES-R) | HADS, PDEQ, IES-R | High |
Åkerman and Langius-Eklof [26] | 2018 | Obs | Patients | 419 | Sweden | Unclear | 2, 6, and 12 months | 3-set 4P | Moderate |
Glimelius Petersson et al. [29] | 2015 | Obs | Patients | 96 | Sweden | ICU discharge | 2 months | PTSS-14 | Serious |
Svenningsen et al. [31] | 2014 | Obs | Patients | 360 | Denmark | 1 week after ICU discharge | 6 months | SF-36 | Serious |
Backman et al. [27] | 2010 | Obs | Patients | 499 | Sweden | Hospital discharge | 6 months | SF-36 | Moderate |